10 Results for "

dependency

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "dependency" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-P72262
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HDAC1; GON-10; Prev. RPD3L1; Reduced Potassium dependency, Yeast Homolog-Like 1; HD1; Protein Decrotonylase HDAC1; Protein Deacetylase HDAC1; Histone Deacetylase; Protein Deacylase HDAC1; RPD3; Histone Deacetylase 1; KDAC1
Species:  
Human
Source:  
E. coli
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-163987
CAS No.: 3061491-60-6
Target:  

Sirtuin

Research Areas:  

Neurological Disease

SIRT3 activator 2 (compound 2a) is a SIRT3 activator. SIRT3 activator 2 improved the thermal stability of SIRT3 in SH-SY5Y cells, indicating that it can directly bind to SIRT3, has SIRT3 dependency in SH-SY5Y to clear α-Syn. SIRT3 activator 2 improves motor function in Parkinson mice, preventing Parkinson (DA) neuron loss in the substantia nigra in a dose-dependent manner .
loading...
    loading...
Cat. No.: HY-W016414
CAS No.: 78-40-0
Triethyl phosphate is a versatile phosphate ester compound. Triethyl phosphate induces rapid and short-acting anesthesia, and exhibits hypotensive, smooth muscle relaxant, and cardiac inhibitory effects. Triethyl phosphate also modulates cholinergic toxicity; its anesthetic effect shows sex- and age-dependency in rodents, and it interacts with SKF 525-A (HY-B1311) to alter the duration of anesthesia .
loading...
    loading...
Cat. No.: HY-153847
Research Areas:  

Others

RNA Aptamer Mango Ⅱ (sodium) has an exceptionally high affinity to TO1-biotin (a thiazole orange derivative fluorophore), and can be used to visualize RNA expression or localization in live cells. Compared to the original Mango I aptamer, RNA Aptamer Mango Ⅱ (sodium) has markedly improved fluorescent properties, binding affinities, and salt dependencies.
loading...
    loading...
Cat. No.: HY-155099
CAS No.: 3033813-47-4
FGH31 (Compound 24) is a potent, selective, GRK2 dependency dopamine D4 agonist, with the Ki of 1.6 nM. FGH31 partial activates β- arrestin .
loading...
    loading...
Cat. No.: HY-106659
CAS No.: 873947-10-5
Synonyms: NK-1 Antagonist 1
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Endocrinology

SCH 900978 (NK-1 Antagonist 1) is an antagonist of NK-1 receptor, used in the research of NK-1 related diseases and conditions such as cough, overactive bladder, alcohol dependency and depression .
loading...
    loading...
RNA Aptamer Mango Ⅳ sodium
0 Images
5'-GGCACGUAC-CGA-GG-GAGU-GG- UGA -GG-AUGA- -GG-CGA-----GUACGUGC-3', sodium salt
Cat. No.: HY-153848
RNA Aptamer Mango Ⅳ (sodium) has an exceptionally high affinity to TO1-biotin (a thiazole orange derivative fluorophore), and can be used to visualize RNA expression or localization in live cells. Compared to the original Mango I aptamer, RNA Aptamer Mango Ⅳ has markedly improved fluorescent properties, binding affinities, and salt dependencies.
loading...
    loading...
RNA Aptamer Mango Ⅲ sodium
0 Images
5'-GGCACGUACGAAGGAAGGAUUGGUAUGUGGUAUAUUCGUACGUGCC-3', sodium salt
Cat. No.: HY-153849
RNA Aptamer Mango Ⅲ (sodium) has an exceptionally high affinity to TO1-biotin (a thiazole orange derivative fluorophore), and can be used to visualize RNA expression or localization in live cells. Compared to the original Mango I aptamer, RNA Aptamer Mango Ⅲ has markedly improved fluorescent properties, binding affinities, and salt dependencies.
loading...
    loading...
Cat. No.: HY-159923
CAS No.: 2131199-52-3
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

BPRMU191 is a μ-opioid receptor (MOR) modulator that converts small-molecule morphinan antagonists into G protein-biased MOR agonists, thereby inducing MOR-dependent activation and analgesic effects. Co-administration of BPRMU191 with morphinan antagonists provides analgesia while reducing side effects such as gastrointestinal dysfunction, antinociceptive tolerance, and dependency-related adverse effects. BPRMU191, in combination with morphinan antagonists, offers a potential strategy for studying severe pain management and G protein-coupled receptor modulation .
loading...
    loading...
Cat. No.: HY-184556
Research Areas:  

Cancer

dCBP-30 is an orally active, selective and dual-acting CBP/p300 PROTAC degrader with DC50 values of 0.05 nM (CBP) and 0.04 nM (p300), respectively. dCBP-30 reduces the acetylation levels of histone substrates H3K27, H3K18, H2BK5 and H2BK20, downregulates multiple myeloma-specific dependency programs, and induces multiple myeloma cell apoptosis. dCBP-30 triggers tumor regression and prolongs survival in multiple myeloma xenograft mouse models, and exhibits synergistic antiproliferative activity with dexamethasone. dCBP-30 can be used for the research of multiple myeloma .
loading...
    loading...